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Abstract
Highly pathogenic avian influenza viruses (HPAIV) originate from avirulent precursors but differ from all other influenza
viruses by the presence of a polybasic cleavage site in their hemagglutinins (HA) of subtype H5 or H7. In this study, we
investigated the ability of a low-pathogenic avian H5N1 strain to transform into an HPAIV. Using reverse genetics, we
replaced the monobasic HA cleavage site of the low-pathogenic strain A/Teal/Germany/Wv632/2005 (H5N1) (TG05) by a
polybasic motif from an HPAIV (TG05poly). To elucidate the virulence potential of all viral genes of HPAIV, we generated two
reassortants carrying the HA from the HPAIV A/Swan/Germany/R65/06 (H5N1) (R65) plus the remaining genes from TG05
(TG05-HAR65) or in reversed composition the mutated TG05 HA plus the R65 genes (R65-HATG05poly). In vitro, TG05poly and
both reassortants were able to replicate without the addition of trypsin, which is characteristic for HPAIV. Moreover, in
contrast to avirulent TG05, the variants TG05poly, TG05-HAR65, and R65-HATG05poly are pathogenic in chicken to an increasing
degree. Whereas the HA cleavage site mutant TG05poly led to temporary non-lethal disease in all animals, the reassortant
TG05-HAR65 caused death in 3 of 10 animals. Furthermore, the reassortant R65-HATG05poly displayed the highest lethality as 8
of 10 chickens died, resembling ‘‘natural’’ HPAIV strains. Taken together, acquisition of a polybasic HA cleavage site is only
one necessary step for evolution of low-pathogenic H5N1 strains into HPAIV. However, these low-pathogenic strains may
already have cryptic virulence potential. Moreover, besides the polybasic cleavage site, the additional virulence
determinants of H5N1 HPAIV are located within the HA itself and in other viral proteins.
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Introduction
Highly pathogenic avian influenza viruses (HPAIV) are the
causative agents of fowl plague [1,2] which causes devastating
economic losses in gallinaceous poultry. In addition, several
HPAIV strains are able to infect humans and, therefore, are
considered as potential precursors for future influenza pandemics
[3]. For infection, the envelope glycoprotein hemagglutinin (HA)
precursor HA0 requires proteolytic cleavage by cellular proteases
into the two subunits HA1 and HA2. Mammalian and low-
pathogenic avian influenza A viruses (LPAIV) carry an HA
cleavage site with a monobasic motif susceptible to trypsin-like
proteases which confine viral replication to the respiratory or
gastrointestinal tract. In contrast, HPAIV possess a polybasic HA
cleavage site cleavable by furin [4,5], which is ubiquitous and thus
supports systemic viral replication. This polybasic HA cleavage site
is the prime virulence determinant of HPAIV [6,7,8] which
originate from LPAIV precursors [4,9,10,11,12,13,14,15,16].
Acquisition of a furin recognition motif was shown to result from
different events such as recombination of the HA gene with 28S
ribosomal RNA [17] or with sequences encoding other viral
proteins like the nucleoprotein (NP) gene of an unrelated virus [15]
or the HA and matrix protein genes (M) from the same virus [16].
An alternative proposed mechanism is polymerase slippage on
template regions with stable secondary structures [13,14]. In
mammalian influenza viruses, virulence determinants have been
attributed to the HA [18,19,20,21,22], NA [18,23], NS1 [24,
25,26,27,28], NP and polymerase proteins [18,29,30,31,32,
33,34]. In HPAIV, beside the polybasic HA cleavage site, the
caspase cleavage motif in the M2 protein and deletions within the
NA stalk region were associated with increased virulence
[35,36,37,38,39,40]. Furthermore, introduction of the NS gene
from an H5N1 HPAIV into an H7N1 fowl plague strain rendered
it virulent for mice [41]. Recently, we demonstrated that the
acquisition of a polybasic cleavage site by an LPAIV H3N8 strain
is not sufficient for immediate transformation into an HPAIV, and
that additional virulence determinants other than the polybasic
HA cleavage site are required [42]. However, it remained to be
analyzed whether H5 or H7 LPAIV, which are considered
HPAIV precursors, have to undergo further evolutionary changes
prior to or after acquisition of a polybasic cleavage site. Therefore,
we addressed in this study the question whether a polybasic
PLoS ONE | www.plosone.org 1 July 2010 | Volume 5 | Issue 7 | e11826cleavage site engineered into the HA of an H5N1 LPAIV leads to
immediate transformation into an HPAIV. To elucidate the
virulence potential of all viral genes of H5N1 HPAIV in chicken
further, we generated two H5N1 reassortants carrying an HPAIV
HA plus the remaining LPAIV genes, or, in reversed composition,
the LPAIV HA with engineered polybasic cleavage site plus the
HPAIV genes.
Results
Generation of Recombinant Viruses
As parental strains we used a recent H5N1 LPAIV isolated in
Germany in 2005, A/Teal/Germany/Wv632/2005 (H5N1) [43]
as well as the first HPAIV H5N1 isolate derived from the outbreak
in wild swans on the island of Ru ¨gen in February 2006, A/Swan/
Germany/R65/06 (H5N1) [44]. First, plasmid-based reverse
genetics systems were established for both strains, resulting in
the recombinant viruses TG05 (this study) and R65 [45],
respectively. To introduce a polybasic HA cleavage site into
TG05 (H5N1), we replaced its monobasic HA cleavage site with a
polybasic motif from HPAIV A/Duck/Shanghai/13/01 (H5N1)
by site-directed mutagenesis and used this plasmid for generation
of the mutant TG05poly. Considering possible structural con-
straints within the HA of the parental TG05, we also adapted the
amino acids adjacent to the cleavage site to those from the HA of
A/Duck/Shanghai/13/01 (H5N1) (Table 1). Furthermore, we
rescued two reassortants carrying the HA from HPAIV R65 plus
the remaining seven genes from TG05 (TG05-HAR65), or, in
reversed composition, the mutated TG05 HA plus the remaining
R65 genes (R65-HATG05poly). Remarkably, we could not rescue a
mutant of TG05 with the polybasic cleavage site region from R65
suggesting structural impairments of the mutated HA.
TG05poly has in-vitro properties of an HPAIV
To address the question whether the HA cleavage site mutant
and the two reassortants are dependent on trypsin for multicycle
replication, we performed plaque assays. Whereas the parental
TG05 required exogenous trypsin for plaque formation, all the
viruses with a polybasic HA cleavage site, TG05poly, TG05-
HAR65, and R65-HATG05poly, yielded plaques independent of
trypsin (Fig. 1). Proteolytic HA cleavage was analyzed by
immunoblotting. Corresponding to plaque assays, the HA0
precursor of TG05 remained uncleaved in the absence of trypsin
in contrast to HA0 of TG05poly, TG05-HAR65, and R65-
HATG05poly (Fig. 2), which were cleaved into the HA1 and HA2
fragments. The HA0 cleavage was incomplete in all viruses
studied. Multicycle growth kinetics of TG05 showed a strong
dependence on exogenous trypsin as the virus failed to replicate
efficiently in the absence of trypsin. TG05poly replicated both in
the presence and in the absence of trypsin, although with a delay
compared with the other viruses. However, both reassortant
viruses TG05-HAR65 and R65-HATG05poly replicated to high titers
irrespective of trypsin (Fig. 3). In summary, these results
demonstrate that TG05poly, TG05-HAR65, and R65-HATG05poly
undergo multicycle replication in the absence of trypsin in contrast
to their parent virus TG05 and, thus, display HPAIV phenotypes
in-vitro.
Pathogenicity in chicken
To investigate the virulence of TG05, TG05poly, TG05-HAR65,
and R65-HATG05poly in chicken, 10 animals each were infected
with 10
5 pfu of the respective virus oculonasally, and observed
daily for clinical symptoms for 10 days (Table 2 and Fig. 4). In
contrast to the low-pathogenic parental virus TG05 which proved
to be completely innocuous as expected, the HA cleavage site
mutant TG05poly and the two reassortants TG05-HAR65 and R65-
HATG05poly were pathogenic in chicken to an increasing degree.
Infection with TG05poly led to temporary non-lethal disease in all
animals (predominantly mild symptoms such as ruffled feathers,
depression or diarrhea mainly from day 3 to 6). After inoculation
with TG05-HAR65 3 of 10 animals died, whereas R65-HATG05poly
displayed the highest lethality as 8 of 10 infected chickens died,
thus exhibiting the phenotype of a natural HPAIV (Table 2).
Organ tropism and tissue lesions in chicken
On day 4 post inoculation, samples from cerebellum, cerebrum,
lung, nose, trachea, caecum, duodenum, kidney, and pancreas
from three (TG05, TG05poly and TG05-HAR65) and four (R65-
HATG05poly) additionally infected birds per group were removed
and investigated for viral spread in organs and the extent of lesions
in affected tissues. No influenza virus antigen or histomorpholog-
ical lesions were found in organs of TG05 infected birds. In one of
the three TG05poly-inoculated birds, single positive neurons,
pneumocytes II, endothelial cells, lymphocytes, and macrophages
could be detected in cerebrum, lung, nasal conchae, trachea,
caecum, and duodenum. Furthermore, in one TG05-HAR65-
infected bird, small clusters of infected cells were present in
cerebellum and cerebrum suggesting that already the introduction
of the R65 HA facilitates neurotropism.
All four R65-HATG05poly-infected birds exhibited larger and
more intensely stained clusters of infected cells within cerebellum,
cerebrum, and nasal mucosae; several birds displayed single
positive cells in lung, trachea, caecum, duodenum, kidney, and
pancreas. After infection with the recombinant HPAIV R65 [45],
the picture of infected cells appeared more intense (Table 3, Fig. 5).
These results demonstrate a broader organ tropism of R65-
HATG05poly-inoculated birds compared with TG05poly-inoculated
birds demonstrating the relevance of the other viral genes for
systemic spread.
On day 10 post inoculation, organs were removed from four
surviving birds each of the TG05, TG05poly and TG05-HAR65-
infected groups. No antigen was detectable in tissues of these birds,
except for a few positive neurons and glial cells in the cerebellum
from one TG05-HAR65-infected bird, and in the cerebrum from
Table 1. Generated viruses and their HA cleavage sites.
Abbreviation Description HA Cleavage Site
TG05 A/Teal/Germany/Wv632/05 (H5N1) recombinant, monobasic cleavage site GPRNVPQKET ----R / G
TG05poly Recombinant TG05 with polybasic cleavage site from A/Duck/Shanghai/13/01 (H5N1) GLRNTPQRERRRKKR/G
TG05-HAR65 Reassortant from TG05 with HA gene from A/Swan/Germany/R65/06 (H5N1) GLRNSPQGERRRKKR/G
R65-HATG05poly Reassortant from R65 with HA gene from TG05poly GLRNTPQRERRRKKR/G
doi:10.1371/journal.pone.0011826.t001
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inflammatory cells in the nasal mucosa from one of those birds,
demonstrating the recovery of the animals (Table S1).
Taken together, the presence of influenza virus antigen
corresponded to degeneration and necrosis of the affected tissues
accompanied by lymphocytic and histiocytic infiltration. Extent of
organ tropism and severity of lesions corroborate with the course
of disease. In HPAIV, viral neurotropism can be facilitated by the
HA gene solely and systemic spread is mediated also by the
internal protein genes.
Discussion
Influenza virus virulence is a polygenic trait which had been
established by generating reassortants neurovirulent for mice from
two apathogenic strains, and reassortants apathogenic in chicken
from two virulent strains [46,47]. Furthermore, reassortment
studies based on two H5N1 HPAIV strains revealed that the
exchange of the HA, NP, M2 or NS1 proteins resulted in
increased mortalities and expanded tissue tropism in chicken.
Moreover, replacement of the PB2 or PB1 proteins led to
decreased replication in tissues and, consequently, a decrease in
virulence [48]. These findings can be attributed to involvement of
these proteins in virulence or to constraints of gene segment
exchanges by reassortment in HPAIV. However, the prime
determinant of virulence is the polybasic HA cleavage site
[6,7,8] as its conversion into a monobasic motif invariably resulted
in loss of virulence [7]. On the other hand, introduction of such a
polybasic motif into the HA cleavage site of a low-pathogenic
H3N8 strain did not lead to transformation into an HPAIV
indicating the existence of additional virulence determinants in the
HA and/or the other viral proteins [42].
To shed more light on virulence determinants required for
evolution of HPAIV which, in nature, derive from low-pathogenic
precursors of subtypes H5 or H7 [4,9,10,11,12,13,14,15,16], we
addressed the question whether a low-pathogenic avian strain of
the H5N1 subtype would transform into a highly pathogenic strain
after introduction of a polybasic HA cleavage site. For that
purpose, we replaced the monobasic HA cleavage site from TG05
by a polybasic motif from the HPAIV A/Duck/Shanghai/13/01
(H5N1) resulting in the mutant TG05poly. Remarkably, attempts
to obtain a similar mutant with the HA cleavage site of HPAIV
R65 were not successful indicating structural incompatibilities with
the TG05 HA.
Although TG05poly was able to replicate in the absence of
trypsin in cell-culture, and, thus, exhibits the in-vitro phenotype of
Figure 1. Multicycle replication in-vitro. Plaque assays of TG05 in comparison with TG05poly, TG05-HAR65, and R65-HATG05poly on MDCK cells in
the presence and in the absence of trypsin.
doi:10.1371/journal.pone.0011826.g001
Figure 2. Proteolytic HA activation. Western blots of DF-1 cell
lysates infected with TG05, TG05poly, TG05-HAR65 or R65-HATG05poly at
multiplicity of infection of 0.1 incubated in the presence (T) and in the
absence (-) of trypsin.
doi:10.1371/journal.pone.0011826.g002
Figure 3. Growth kinetics. DF-1 cells were inoculated with TG05
(blue), TG05poly (magenta), TG05-HAR65 (yellow), and R65-HATG05poly
(red) at multiplicity of infection 10
23 in the presence (diamonds) and in
the absence (circles) of trypsin.
doi:10.1371/journal.pone.0011826.g003
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chicken and, accordingly, could be detected only in isolated single
cells accompanied with minor lesions in affected organs. These
observations differ from those obtained by the H3N8 polybasic
cleavage site mutants generated from the LPAIV A/Duck/
Ukraine/1/1963 which caused considerably less symptoms in
chicken [42] compared with TG05poly indicating that the low-
pathogenic H5N1 strain already carried cryptic virulence
determinants. Correspondingly, repeated air sac inoculation of a
low-pathogenic H5N3 isolate in 1-day-old-chickens did not lead to
high virulence for 4-to-6-week-old chickens, whereas only two
further passages in brain yielded an HPAIV [49].
To demonstrate the existence of virulence determinants besides
the polybasic cleavage site in the HA or in other genes of H5N1
HPAIV, we generated two reassortants, TG05-HAR65 carrying
the HA from the HPAIV R65 plus the remaining seven genes
from TG05 and, in reverse gene constellation, R65-HATG05poly
composed of the mutated TG05 HA plus the other R65 genes.
Whereas TG05-HAR65 already had a lethality of 30%, R65-
HATG05poly caused a lethality of 80%, displaying the phenotype of
a ‘‘natural’’ HPAIV. These findings indicate that in H5N1 HPAIV
the HA gene alone provides for a certain level of virulence,
whereas the complete viral genetic background influences
pathogenicity to a major extent.
Compared with the very broad organ tropism of the HPAIV
R65 in chicken [50], the mutant TG05poly and the two
reassortants TG05-HAR65 and R65-HATG05poly displayed gener-
ally less viral spread in organs and less extensive lesions in
surrounding tissues. However, spread and lesions increased with
the two reassortants from which R65-HATG05poly exhibited the
phenotype of an authentic HPAIV. This finding again emphasizes
the relevance of HA and the other viral genes for virulence.
Moreover, all birds which had viral antigen detectable in inner
organs, i.e. those infected by TG05poly, TG05-HAR65 or R65-
HATG05poly also exhibited a neuronal infection. Thus, the presence
of the HPAIV R65 HA alone in a LPAIV background suffices for
viral neurotropism which is considered pivotal for the fatal course
of fowl plague [51,52,53].
Previous studies on HPAIV strains revealed that (1) removal of
the polybasic HA cleavage site results in a drastic decrease in
pathogenicity [7]; (2) virulence is a multigenic trait as reassortants
derived from HPAI strains can be attenuated [46], two LPAI
strains can reassort to a highly virulent virus [47] and reassortants
with exchanged HA, NP, M or NS, PB2 or PB1 gene have an
altered virulence [48]; (3) NA stalk deletion leads to a certain
increase in virulence in an LPAIV [40]; and (4) NS1 can increase
virulence of an HPAIV further [41]. Most of these studies started
from HPAIV and measured a decline in pathogenicity, which
demonstrates that the identified alterations were required for full
expression of virulence, or resulted from reassortment events
which are prone to incompatibilities. No study so far addressed the
question whether acquisition of a polybasic cleavage site is
sufficient to transform a LPAIV H5 precursor into a highly
pathogenic H5 virus. However, knowledge on this problem is most
relevant, since it is required for development of a science-based
assessment of the risk of HPAIV emergence from LPAIV field
strains. Therefore, we introduced a polybasic HA cleavage site into
the low-pathogenic H5N1 strain TG05, a potential HPAI
precursor virus, in order to model the early evolution of HPAIV.
This approach complements the current knowledge on the relative
importance of virulence determinants and HPAIV evolution from
the opposite point of view.
Taken together, acquisition of a polybasic HA cleavage site is
only one necessary step for evolution of H5N1 HPAIV from low-
pathogenic precursor strains, which may already have cryptic
virulence potential. Moreover, besides the polybasic HA cleavage
site, additional virulence determinants of HPAIV are located
within the HA itself and in the other viral proteins. Knowledge of
these virulence factors is crucial for an assessment of the risk of
transformation of any LPAIV to HPAIV which is highly relevant
for the control of notifiable LPAIV H5 or H7 infections in poultry.
Material and Methods
Ethics Statement
The animal experiments were evaluated by the responsible
ethics committee of the State Office for Agriculture, Food Safety
and Fishery in Mecklenburg-Western Pomerania (LALFF M-V)
and gained governmental approval (registration number LALLF
M-V/TSD/7221.3-1.1-018/07).
Cells and Viruses
Human embryonic kidney 293T [32] and Madin-Darby canine
kidney (MDCK) cells [32] were maintained in DMEM containing
10% fetal calf serum (FCS). Chicken fibroblast cells (DF-1) were
cultured in ISCOVES DMEM containing 10% FCS in the
absence of antibiotics. The low-pathogenic avian influenza A virus
A/Teal/Germany/Wv632/2005 (H5N1) (TG05) was isolated
from a healthy green winged teal (Anas crecca) [43]. The sequences
of cloned viral genes have been submitted to Genbank (accession
numbers CY061882-9). A/Swan/Germany/R65/06 (H5N1)
(R65) was isolated from a dead swan during the HPAIV outbreak
Figure 4. Virulence in chicken. Daily clinical score after oculonasal
inoculation with 10
5 pfu of TG05 (blue), TG05poly (magenta), TG05-HAR65
(yellow) or R65-HATG05poly (red). The birds were observed for 10 days for
clinical signs and classified as healthy (0), ill (1), severely ill (2), or dead
(3); the daily clinical score was calculated from the sum of individual
clinical scores from all birds divided by the number of animals per
group (10 chickens).
doi:10.1371/journal.pone.0011826.g004
Table 2. Virulence in chickens.
Virus Clinical Score Morbidity Mortality
TG05 0.0 0/10 0/10
TG05poly 0.5 10/10 0/10
TG05-HAR65 0.9 8/10 3/10
R65-HATG05poly 2.1 10/10 8/10
Clinical score, morbidity, and mortality after 10 days observation following
oculonasal infection.
doi:10.1371/journal.pone.0011826.t002
HPAIV Virulence Determinants
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DQ464354-DQ464361) [44]. Both native viruses were propagated
in 11-day-old embryonated chicken eggs.
Generation of recombinant viruses
Viral genes from TG05 were cloned into the plasmid
pHWSccdB as described in [45]. Site-directed mutagenesis of
the HA cleavage site region was performed by the Quikchange
TM
protocol (primer sequences available upon request). All recombi-
nant viruses were rescued essentially as described [32] with the
addition of plasmids expressing the polymerase proteins and the
nucleoprotein genes from A/PR/8/34 (H1N1) (a kind gift from
Peter Palese) except for R65-HATG05poly. The recombinant R65
[45] differs from the native isolate [44] by 4 nucleotide exchanges
in the PB2 gene (DQ464357): C1009T corresponding to the
amino acid replacement L329F, in the PB1 gene (DQ464361):
A1603G and G1604T corresponding to the amino acid replace-
ment S527V, and in the HA gene (DQ464354): C1737T in non-
coding region. TG05 was propagated in embryonated eggs, all
other recombinant viruses were grown on MDCK cells. Gene
composition and HA cleavage site of the generated viruses were
verified by sequencing of amplicons from reverse transcription-
PCR (data not shown). All viruses with polybasic HA cleavage site
were handled under BSL3+ conditions.
Figure 5. Viral organ tropism in chicken. Immunohistochemical detection of influenza A virus nucleoprotein (brown) in lung and cerebellum
from chickens sacrificed on day 4 post inoculation with 10
5 pfu of TG05 or R65-HATG05poly, and from moribund chickens sacrificed on day 2 post
inoculation with 10
6 TCID50 R65.
doi:10.1371/journal.pone.0011826.g005
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Plaque assays were performed on MDCK cells as described
previously [54] with 400 ml inoculum either in the presence of
2 mg/ml N-tosyl-L-phenylalanine chloromethyl ketone (TPCK)-
treated trypsin (Sigma, Taufkirchen, Germany), or in the absence
of trypsin. For determination of growth curves, DF-1 cells were
inoculated at a multiplicity of infection of 10
23 in the presence of
1 mg/ml TPCK-treated trypsin or in the absence of any exogenous
protease. From two independent experiments, supernatants were
harvested at 0, 8, 24, 48, and 72 h post inoculation and resulting
infectious virus was titrated by plaque assay on MDCK cells in the
presence of trypsin.
Western blots
DF-1 cells were infected at a multiplicity of infection of 0.1 in
the presence of either 1.0 mg/ml TPCK-treated trypsin or no
exogenous protease in ISCOVES DMEM and 0.2% bovine serum
albumin (BSA) (MP Medicals, Heidelberg) until a cytopathic effect
appeared (48 h for TG05, TG05-HAR65, and R65-HATG05poly;
7 d for TG05poly). Cells were lysed with 46Laemmli buffer [55]
containing 4% sodium dodecyl sulfate (SDS) and were inactivated
by heating at 95uC for 5 min. Lysates were separated on a 10%-
SDS polyacrylamid gel and electrotransferred to a nitrocellulose
membrane. For detection of HA, a polyclonal rabbit antibody to
the HA protein from A/Chicken/Vietnam/P41/2005 (H5N1),
expressed by a vaccinia virus vector [56], (1:20,000; incubated 1 h
at room temperature) and as secondary antibody a rabbit-specific
goat immunoglobulin G fragment conjugated with horseradish
peroxidase (1:10,000; 1 h at room temperature, Biovision, USA)
were used. Antibody binding was visualized by chemiluminescence
(Supersignal West Pico Chemiluminescence Kit from Pierce,
Bonn).
Animal experiments
Ten 2-week-old White Leghorn specific-pathogen-free chickens
per group were infected oculonasally with 10
5 PFU per animal.
Each bird was observed daily for 10 days for clinical signs and
classified as healthy (0), ill (1) (exhibiting one of the following:
respiratory symptoms, depression, diarrhea, cyanosis, edema, or
central nervous symptoms), severely ill (2) (severe or more than one
of the previously mentioned symptoms), or dead (3) as described
previously [57]. When birds are too sick to eat or drink, they are
killed humanely and scored as dead to the next observation day
[57].
Histopathology and immunohistochemistry
Samples from cerebellum, cerebrum, lung, nose, trachea,
caecum, duodenum, kidney, and pancreas of additionally infected
chicken were taken on day 4 and 10 post infection, formalin-fixed
and processed for paraffin-wax-embedding according to standard-
ized procedures. Immunohistochemical detection of influenza A
virus nucleoprotein (NP) and hematoxylin eosin staining was
performed as described [58].
For R65 [45], samples from cerebellum and lung were taken on
day 2 from two 3-week old chickens infected oculonasally with 10
6
TCID50/animal.
Supporting Information
Table S1 Organ tropism and tissue lesions on day 10.
Immunohistochemical detection (IHC) of influenza virus nucleo-
protein antigen and HE staining of organs from chickens after
intranasal inoculation.
Found at: doi:10.1371/journal.pone.0011826.s001 (0.04 MB
DOC)
Acknowledgments
We thank E. Hoffmann and R. G. Webster for the pHW2000 plasmid and
Peter Palese for the pCAGGS(PR8)-PB2, -PB1, -PA, and -NP expression
plasmids. We are very grateful to A. Globig and T. Harder for providing us
with influenza A virus A/Teal/Germany/Wv632/2005 (H5N1), to
Mikhail Matrosovich for the gift of MDCK cells and to Cindy Meinke,
Kathrin Mu ¨ller, Anne Brandenburg, Thorsten Arnold, Georg Bauer, and
Gerda Busch for very skillful technical assistance.
Author Contributions
Conceived and designed the experiments: JV OS TM JS. Performed the
experiments: JB JV SG JH AB. Analyzed the data: JB JV AB JT TM JS.
Contributed reagents/materials/analysis tools: JB SG JH OS JS. Wrote the
paper: JB AB JT TM JS.
References
1. Schaefer W (1955) Vergleichende seroimmunologische Untersuchungen u ¨ber
die Viren der Influenza und der klassischen Geflu ¨gelpest. Z Naturforsch 10b:
81–91.
2. Swayne DE (2007) Understanding the complex pathobiology of high
pathogenicity avian influenza viruses in birds. Avian Dis 51: 242–249.
3. Peiris JS, de Jong MD, Guan Y (2007) Avian influenza virus (H5N1): a threat to
human health. Clin Microbiol Rev 20: 243–267.
4. Garten W, Klenk HD (1999) Understanding influenza virus pathogenicity.
Trends Microbiol 7: 99–100.
5. Stieneke-Grober A, Vey M, Angliker H, Shaw E, Thomas G, et al. (1992)
Influenza virus hemagglutinin with multibasic cleavage site is activated by furin,
a subtilisin-like endoprotease. EMBO J 11: 2407–2414.
6. BoschFX,OrlichM,Klenk HD,RottR(1979)Thestructureofthehemagglutinin,
a determinant for the pathogenicity of influenza viruses. Virology 95: 197–207.
7. Horimoto T, Kawaoka Y (1994) Reverse genetics provides direct evidence for a
correlation of hemagglutinin cleavability and virulence of an avian influenza A
virus. J Virol 68: 3120–3128.
8. Senne DA, Panigrahy B, Kawaoka Y, Pearson JE, Suss J, et al. (1996) Survey of
the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza
viruses: amino acid sequence at the HA cleavage site as a marker of
pathogenicity potential. Avian Dis 40: 425–437.
9. Garten W, Klenk H.-D (2008) Cleavage Activation of the Influenza Virus
Hemagglutinin and Its Role in Pathogenesis In: Klenk H-D, Matrosovich MN,
Stech J, eds. Avian Influenza. Basel: Karger. pp 156–167.
10. Kawaoka Y, Webster RG (1985) Evolution of the A/Chicken/Pennsylvania/83
(H5N2) influenza virus. Virology 146: 130–137.
11. Horimoto T, Rivera E, Pearson J, Senne D, Krauss S, et al. (1995) Origin and
molecular changes associated with emergence of a highly pathogenic H5N2
influenza virus in Mexico. Virology 213: 223–230.
12. Rohm C, Horimoto T, Kawaoka Y, Suss J, Webster RG (1995) Do
hemagglutinin genes of highly pathogenic avian influenza viruses constitute
unique phylogenetic lineages? Virology 209: 664–670.
13. Garcia M, Crawford JM, Latimer JW, Rivera-Cruz E, Perdue ML (1996)
Heterogeneity in the haemagglutinin gene and emergence of the highly
pathogenic phenotype among recent H5N2 avian influenza viruses from
Mexico. J Gen Virol 77(Pt 7): 1493–1504.
14. Perdue ML, Garcia M, Senne D, Fraire M (1997) Virulence-associated sequence
duplication at the hemagglutinin cleavage site of avian influenza viruses. Virus
Res 49: 173–186.
15. Suarez DL, Senne DA, Banks J, Brown IH, Essen SC, et al. (2004)
Recombination resulting in virulence shift in avian influenza outbreak, Chile.
Emerg Infect Dis 10: 693–699.
16. Pasick J, Handel K, Robinson J, Copps J, Ridd D, et al. (2005) Intersegmental
recombination between the haemagglutinin and matrix genes was responsible
for the emergence of a highly pathogenic H7N3 avian influenza virus in British
Columbia. J Gen Virol 86: 727–731.
17. Khatchikian D, Orlich M, Rott R (1989) Increased viral pathogenicity after
insertion of a 28S ribosomal RNA sequence into the haemagglutinin gene of an
influenza virus. Nature 340: 156–157.
18. de Wit E, Munster VJ, van Riel D, Beyer WE, Rimmelzwaan GF, et al. (2009)
Molecular determinants of adaptation of HPAI H7N7 viruses to efficient
replication in the human host. J Virol.
HPAIV Virulence Determinants
PLoS ONE | www.plosone.org 7 July 2010 | Volume 5 | Issue 7 | e1182619. Kawaoka Y, Naeve CW, Webster RG (1984) Is virulence of H5N2 influenza
viruses in chickens associated with loss of carbohydrate from the hemagglutinin?
Virology 139: 303–316.
20. Kobasa D, Takada A, Shinya K, Hatta M, Halfmann P, et al. (2004) Enhanced
virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic
virus. Nature 431: 703–707.
21. Pappas C, Aguilar PV, Basler CF, Solorzano A, Zeng H, et al. (2008) Single gene
reassortants identify a critical role for PB1, HA, and NA in the high virulence of
the 1918 pandemic influenza virus. Proc Natl Acad Sci U S A 105: 3064–3069.
22. Tumpey TM, Maines TR, Van Hoeven N, Glaser L, Solorzano A, et al. (2007)
A two-amino acid change in the hemagglutinin of the 1918 influenza virus
abolishes transmission. Science 315: 655–659.
23. Matsuoka Y, Swayne DE, Thomas C, Rameix-Welti MA, Naffakh N, et al.
(2009) Neuraminidase stalk length and additional glycosylation of the
hemagglutinin influence the virulence of influenza H5N1 viruses for mice.
J Virol 83: 4704–4708.
24. Fernandez-Sesma A, Marukian S, Ebersole BJ, Kaminski D, Park MS, et al.
(2006) Influenza virus evades innate and adaptive immunity via the NS1 protein.
J Virol 80: 6295–6304.
25. Jiao P, Tian G, Li Y, Deng G, Jiang Y, et al. (2008) A single-amino-acid
substitution in the NS1 protein changes the pathogenicity of H5N1 avian
influenza viruses in mice. J Virol 82: 1146–1154.
26. Li Z, Jiang Y, Jiao P, Wang A, Zhao F, et al. (2006) The NS1 gene contributes to
the virulence of H5N1 avian influenza viruses. J Virol 80: 11115–11123.
27. Lipatov AS, Andreansky S, Webby RJ, Hulse DJ, Rehg JE, et al. (2005)
Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice:
the role of cytokines and B- and T-cell responses. J Gen Virol 86: 1121–1130.
28. Seo SH, Hoffmann E, Webster RG (2002) Lethal H5N1 influenza viruses escape
host anti-viral cytokine responses. Nat Med 8: 950–954.
29. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA,
et al. (2004) Avian influenza A virus (H7N7) associated with human
conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl
Acad Sci U S A 101: 1356–1361.
30. Hatta M, Gao P, Halfmann P, Kawaoka Y (2001) Molecular basis for high
virulence of Hong Kong H5N1 influenza A viruses. Science 293: 1840–1842.
31. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, et al. (2006) Fatal
outcome of human influenza A (H5N1) is associated with high viral load and
hypercytokinemia. Nat Med 12: 1203–1207.
32. Gabriel G, Dauber B, Wolff T, Planz O, Klenk HD, et al. (2005) The viral
polymerase mediates adaptation of an avian influenza virus to a mammalian
host. Proc Natl Acad Sci U S A 102: 18590–18595.
33. Salomon R, Franks J, Govorkova EA, Ilyushina NA, Yen HL, et al. (2006) The
polymerase complex genes contribute to the high virulence of the human H5N1
influenza virus isolate A/Vietnam/1203/04. J Exp Med 203: 689–697.
34. Snyder MH, Buckler-White AJ, London WT, Tierney EL, Murphy BR (1987)
The avian influenza virus nucleoprotein gene and a specific constellation of
avian and human virus polymerase genes each specify attenuation of avian-
human influenza A/Pintail/79 reassortant viruses for monkeys. J Virol 61:
2857–2863.
35. Baigent SJ, McCauley JW (2001) Glycosylation of haemagglutinin and stalk-
length of neuraminidase combine to regulate the growth of avian influenza
viruses in tissue culture. Virus Res 79: 177–185.
36. Banks J, Speidel ES, Moore E, Plowright L, Piccirillo A, et al. (2001) Changes in
the haemagglutinin and the neuraminidase genes prior to the emergence of
highly pathogenic H7N1 avian influenza viruses in Italy. Arch Virol 146:
963–973.
37. Deshpande KL, Naeve CW, Webster RG (1985) The neuraminidases of the
virulent and avirulent A/Chicken/Pennsylvania/83 (H5N2) influenza A viruses:
sequence and antigenic analyses. Virology 147: 49–60.
38. Hoffmann E, Stech J, Leneva I, Krauss S, Scholtissek C, et al. (2000)
Characterization of the influenza A virus gene pool in avian species in southern
China: was H6N1 a derivative or a precursor of H5N1? J Virol 74: 6309–6315.
39. Zhirnov OP, Klenk HD (2009) Alterations in caspase cleavage motifs of NP and
M2 proteins attenuate virulence of a highly pathogenic avian influenza virus.
Virology 394: 57–63.
40. Munier S, Larcher T, Cormier-Aline F, Soubieux D, Su B, et al. (2010) A
genetically engineered waterfowl influenza virus with a deletion in the stalk of
the neuraminidase has increased virulence for chickens. J Virol 84: 940–952.
41. Ma W, Brenner D, Wang Z, Dauber B, Ehrhardt C, et al. (2010) The NS
segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is
sufficient to alter replication efficiency, cell tropism, and host range of an H7N1
HPAIV. J Virol 84: 2122–2133.
42. Stech O, Veits J, Weber S, Deckers D, Schroer D, et al. (2009) Acquisition of a
polybasic hemagglutinin cleavage site by a low-pathogenic avian influenza virus
is not sufficient for immediate transformation into a highly pathogenic strain.
J Virol 83: 5864–5868.
43. Starick E, Beer M, Hoffmann B, Staubach C, Werner O, et al. (2008)
Phylogenetic analyses of highly pathogenic avian influenza virus isolates from
Germany in 2006 and 2007 suggest at least three separate introductions of
H5N1 virus. Vet Microbiol 128: 243–252.
44. Weber S, Harder T, Starick E, Beer M, Werner O, et al. (2007) Molecular
analysis of highly pathogenic avian influenza virus of subtype H5N1 isolated
from wild birds and mammals in northern Germany. J Gen Virol 88: 554–558.
45. Stech J, Stech O, Herwig A, Altmeppen H, Hundt J, et al. (2008) Rapid and
reliable universal cloning of influenza A virus genes by target-primed plasmid
amplification. Nucleic Acids Res 36: e139.
46. Rott R, Orlich M, Scholtissek C (1976) Attenuation of pathogenicity of fowl
plague virus by recombination with other influenza A viruses nonpathogenic for
fowl: nonexculsive dependence of pathogenicity on hemagglutinin and
neuraminidase of the virus. J Virol 19: 54–60.
47. Scholtissek C, Vallbracht A, Flehmig B, Rott R (1979) Correlation of
pathogenicity and gene constellation of influenza A viruses. II. Highly
neurovirulent recombinants derived from non-neurovirulent or weakly neuro-
virulent parent virus strains. Virology 95: 492–500.
48. Wasilenko JL, Lee CW, Sarmento L, Spackman E, Kapczynski DR, et al. (2008)
NP, PB1, and PB2 viral genes contribute to altered replication of H5N1 avian
influenza viruses in chickens. J Virol 82: 4544–4553.
49. Ito T, Goto H, Yamamoto E, Tanaka H, Takeuchi M, et al. (2001) Generation
of a highly pathogenic avian influenza A virus from an avirulent field isolate by
passaging in chickens. J Virol 75: 4439–4443.
5 0 .P f e i f f e rJ ,P a n t i n - J a c k w o o dM ,T oT L ,N g u y e nT ,S u a r e zD L( 2 0 0 9 )
Phylogenetic and biological characterization of highly pathogenic H5N1 avian
influenza viruses (Vietnam 2005) in chickens and ducks. Virus Res 142:
108–120.
51. Kalthoff D, Breithaupt A, Teifke JP, Globig A, Harder T, et al. (2008) Highly
pathogenic avian influenza virus (H5N1) in experimentally infected adult mute
swans. Emerg Infect Dis 14: 1267–1270.
52. Klopfleisch R, Werner O, Mundt E, Harder T, Teifke JP (2006) Neurotropism
of highly pathogenic avian influenza virus A/chicken/Indonesia/2003 (H5N1)
in experimentally infected pigeons (Columbia livia f. domestica). Vet Pathol 43:
463–470.
53. Perkins LE, Swayne DE (2001) Pathobiology of A/chicken/Hong Kong/220/97
(H5N1) avian influenza virus in seven gallinaceous species. Vet Pathol 38:
149–164.
54. Stech J, Xiong X, Scholtissek C, Webster RG (1999) Independence of
evolutionary and mutational rates after transmission of avian influenza viruses
to swine. J Virol 73: 1878–1884.
55. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the
head of bacteriophage T4. Nature 227: 680–685.
56. Pavlova SP, Veits J, Keil GM, Mettenleiter TC, Fuchs W (2009) Protection of
chickens against H5N1 highly pathogenic avian influenza virus infection by live
vaccination with infectious laryngotracheitis virus recombinants expressing H5
hemagglutinin and N1 neuraminidase. Vaccine 27: 773–785.
57. Alexander DJ (2008) Chapter 2.3.4. Avian influenza. In: Vallat B, ed. Manual of
Diagnostic Tests & Vaccines for Terrestrial Animals. 6th ed: OIE.
58. Kalthoff D, Breithaupt A, Helm B, Teifke JP, Beer M (2009) Migratory status is
not related to the susceptibility to HPAIV H5N1 in an insectivorous passerine
species. PLoS One 4: e6170.
HPAIV Virulence Determinants
PLoS ONE | www.plosone.org 8 July 2010 | Volume 5 | Issue 7 | e11826